General Information of the Compound
Compound ID
CP0526949
Compound Name
5-(benzoylamino)-4-bromo-N-(2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-1H-pyrazole-3-carboxamide
    Show/Hide
Structure
Formula
C26H19BrN6O3
Molecular Weight
543.381
Canonical SMILES
Brc1c(NC(=O)c2ccccc2)n[nH]c1C(=O)NC1N=C(c2ccccc2)c2ccccc2NC1=O
    Show/Hide
InChI
InChI=1S/C26H19BrN6O3/c27-19-21(32-33-22(19)30-24(34)16-11-5-2-6-12-16)25(35)31-23-26(36)28-18-14-8-7-13-17(18)20(29-23)15-9-3-1-4-10-15/h1-14,23H,(H,28,36)(H,31,35)(H2,30,32,33,34)
    Show/Hide
InChIKey
BEPXHHMZTMDGJY-UHFFFAOYSA-N
Physicochemical Property
logP
3.9701
Rotatable Bonds
5
Heavy Atom Count
36
Polar Areas
128.34
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
5
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 23630513
SID: 46491986
ChEMBL ID
CHEMBL390272
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01032, B1 bradykinin receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000411 IMR-90 Homo sapiens (Human)  1
1
IC50 = 49 nM
   TI
   LI
   LO
   TS